Detection of peripheral blood (PB) BCR::ABL1 mRNA levels by quantitative reverse transcription polymerase chain reaction (RT-qPCR) is the most sensitive method for monitoring CML and the efficacy of TKIs. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.